D'Or Institute for Research and Education
Generated by GPT-5-miniExpansion Funnel Raw 82 → Dedup 0 → NER 0 → Enqueued 0
| D'Or Institute for Research and Education | |
|---|---|
| Name | D'Or Institute for Research and Education |
| Native name | Instituto D'Or de Pesquisa e Ensino |
| Established | 2008 |
| Type | Research institute |
| City | Rio de Janeiro |
| Country | Brazil |
| Affiliations | Rede D'Or São Luiz |
D'Or Institute for Research and Education is a Brazilian biomedical research and teaching institute linked to Rede D'Or São Luiz. It operates as a translational research center and postgraduate education provider within the Brazilian health sector, engaging with national and international institutions to advance clinical trials, epidemiology, and medical education.
History
The institute was founded amid an expansion of private healthcare networks such as Rede D'Or São Luiz, Amil, Hospital Israelita Albert Einstein, Hospital Sírio-Libanês, and Grupo Fleury in the late 2000s, paralleling initiatives by Fundação Oswaldo Cruz, Instituto Butantan, Fiocruz, Fundação Getulio Vargas, and Universidade de São Paulo. Early collaborations involved research projects with National Institutes of Health, Wellcome Trust, European Commission, Bill & Melinda Gates Foundation, and Pan American Health Organization, while regulatory interaction occurred with Brazilian Health Regulatory Agency and legal frameworks influenced by Constituição da República Federativa do Brasil de 1988. Institutional milestones included partnerships with University of Oxford, Harvard University, Johns Hopkins University, Imperial College London, and regional cooperation with Universidade Federal do Rio de Janeiro and Fundação Oswaldo Cruz. The institute expanded during public health events that engaged actors like World Health Organization, PAHO, Ministry of Health (Brazil), Zika outbreak, COVID-19 pandemic, SARS-CoV-2 Research and networks including ClinicalTrials.gov and Brazilian National Research Ethics Commission.
Organization and Governance
Governance structures draw on models used by Instituto Butantan, Fiocruz, Hospital Israelita Albert Einstein, Rede D'Or São Luiz, and Albert Einstein Hospital administrative frameworks, with a board that has liaised with figures and organizations such as Ministry of Health (Brazil), Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazilian Development Bank, BNDES, ANVISA and private stakeholders including companies like Orizon and Amil. Leadership roles have interfaced with academic units at Universidade Federal do Rio de Janeiro, Universidade de São Paulo, Pontifícia Universidade Católica do Rio de Janeiro, Fundação Getulio Vargas, and policy actors such as Presidency of Brazil. Institutional governance practices reflected standards from International Committee of Medical Journal Editors, ICH-GCP, World Medical Association, and ethical oversight from Comitê de Ética em Pesquisa.
Research Programs and Facilities
Research programs span translational medicine, clinical trials, infectious disease, noncommunicable diseases, and health services research, integrating methodologies seen at Instituto Butantan, Fiocruz, Hospital Sírio-Libanês, Harvard T.H. Chan School of Public Health, and London School of Hygiene & Tropical Medicine. Facilities include clinical research units, biobanks, genomics laboratories, and simulation centers comparable to those at Broad Institute, Wellcome Sanger Institute, Cambridge Biomedical Campus, Mayo Clinic, and Cleveland Clinic. The institute has hosted protocols registered with ClinicalTrials.gov, collaborative studies with University of Oxford, Imperial College London, Massachusetts General Hospital, Mount Sinai Health System, and partnerships for vaccine research aligned with Instituto Butantan and Bio-Manguinhos. Research themes have intersected with work by WHO, PAHO, Gavi, Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, and international consortia including SPHINX-style networks and multicenter trials mirroring those coordinated by International Severe Acute Respiratory and Emerging Infection Consortium.
Education and Training
Educational programs include postgraduate residencies, continuing medical education, and professional training modeled on offerings from Hospital Israelita Albert Einstein, Hospital Sírio-Libanês, Universidade de São Paulo, Pontifícia Universidade Católica do Rio de Janeiro, and Federal University of Rio de Janeiro. The institute runs courses accredited with Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, fellows participate in exchanges with Harvard Medical School, Johns Hopkins Bloomberg School of Public Health, Karolinska Institutet, University of California, San Francisco, and students engage in supervised clinical teaching similar to programs at Mayo Clinic School of Medicine and University of Oxford Medical School. Training in research ethics, biostatistics, and clinical methodology references guidelines from International Committee of Medical Journal Editors, CONSORT, STROBE, and regulatory expectations of ANVISA.
Clinical Services and Partnerships
Clinical integration aligns with hospitals and networks such as Rede D'Or São Luiz, Hospital São Luiz, Hospital Copa D'Or, Hospital Quinta D'Or, Hospital Samaritano, and partnerships extend to academic hospitals like Hospital das Clínicas da Faculdade de Medicina da USP, Hospital Geral de Fortaleza, and international centers including Mayo Clinic and Cleveland Clinic. Collaborative clinical trials have encompassed antiviral therapeutics, vaccine candidates, critical care protocols, and telemedicine platforms connected with Telemedicine initiatives in Brazil, WHO, and technology partners similar to Philips Healthcare and Siemens Healthineers. Public health collaborations have included municipal health secretariats, Ministry of Health (Brazil), PAHO, and emergency responses during outbreaks such as Zika virus epidemic and COVID-19 pandemic.
Funding and Collaborations
Funding sources combine private investment from Rede D'Or São Luiz, grants from Brazilian Development Bank, research funding from Conselho Nacional de Desenvolvimento Científico e Tecnológico, support from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, and philanthropic grants from Bill & Melinda Gates Foundation, Wellcome Trust, and international funding agencies like the European Commission and National Institutes of Health. Collaborative agreements have been signed with universities and institutes including Universidade de São Paulo, Universidade Federal do Rio de Janeiro, Fundação Oswaldo Cruz, Johns Hopkins University, Harvard University, Imperial College London, and private industry partners analogous to Pfizer, AstraZeneca, GSK, and Sinovac for clinical development and translational projects.